Medicinal Technologies Unveils New OTC Treatments for Pain and Reproductive Health

Dr. Sheryene Tejeda

PHILADELPHIA, PA — Medicinal Technologies, under the leadership of Dr. Sheryene Tejeda, has announced the release of two cutting-edge over-the-counter products, EndoOil and MEnera. These FDA-registered solutions mark a significant step forward in pain management and reproductive health, reflecting the company’s ongoing dedication to enhancing patient outcomes through science-based innovations.

EndoOil: Innovative Approach to Pain Relief

EndoOil is designed to alleviate pain and inflammation associated with conditions such as arthritis, sciatica, burns, and joint discomfort. Building on the success of the 3-step Endogen protocol, this product stands out with its ability to tackle both chronic and injury-related pain independently. Developed by Dr. Tejeda, who holds extensive credentials as a biomedical scientist, EndoOil harnesses the power of plant extracts and scientifically validated compounds. These ingredients work together to target pain receptors and inflammatory pathways effectively.

“EndoOil is crafted to address the root physiological factors contributing to pain,” Dr. Tejeda noted. “It provides significant relief by directly interacting with the body’s pain management systems.”

MEnera: Enhancing Reproductive Health

Complementing EndoOil is MEnera, which is formulated to support hormonal balance, enhance fertility, and ease menopausal symptoms. MEnera aims to regulate menstrual cycles and improve egg quality, offering a natural solution for those facing reproductive health challenges. Dr. Tejeda’s extensive research into reproductive disorders has been instrumental in developing MEnera, ensuring it effectively addresses hormonal imbalances.

“MEnera is the culmination of years of research focused on reproductive health,” Dr. Tejeda commented. “Our goal is to provide women with a reliable means of maintaining hormonal balance and reproductive wellness.”

READ:  Cabaletta Bio Reports Q3 2024 Financial Results and Clinical Trial Advancements
A Legacy of Innovation in Biomedical Treatments

The launch of EndoOil and MEnera underscores Medicinal Technologies’ commitment to pioneering biomedical treatments. Dr. Tejeda’s research extends beyond these areas, covering conditions such as diabetes, hypertension, and ocular disorders. The company collaborates with top medical institutions to ensure rigorous testing and clinical validation of its products.

Medicinal Technologies continues to lead in integrative biomedicine, offering plant-based solutions to complex health issues, thereby improving patients’ quality of life. Both EndoOil and MEnera are now available, presenting new opportunities for individuals seeking effective pain management and reproductive health support.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.